Document is current
Any future updates will be listed below
-
Authors
Scheid, Jonas
Lemke, Steffen
Hoenisch-Gravel, Naomi
Dengler, Anna
Sachsenberg, Timo
Declerq, Arthur
Gabriels, Ralf
Bauer, Jens
Wacker, Marcel
Bichmann, Leon
Martens, Lennart
Dubbelaar, Marissa L.
Nahnsen, Sven
Walz, Juliane S.
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek,Belgium (12B7123N, G010023N, G028821N, 1SE3724N)
HORIZON EUROPE Project BAXERNA 2.0 (101080544)
CHIST-ERA (ODEEP-EU)
Deutsche Forschungsgemeinschaft (EXC2180-390900677)
Deutsche Krebshilfe (70114948)
Else Kröner-Fresenius-Stiftung (2022_EKSE.79)
Invest BW Innovation grant (BW1_4064/03/TruVac)
Eberhard Karls Universität Tübingen
- License Information
-
More Information
Article History
Received: 12 February 2025
Accepted: 30 August 2025
First Online: 22 September 2025
Declarations
:
: The study was approved by the Cantonal Ethics Committee Zürich (KEK) (BASEC-Nr. Req-2016–00604). For none of the included patients, a refusal of post-mortem contribution to medical research was documented, and study procedures are in accordance with applicable Swiss law for research on humans (Bundesgesetz über die Forschung am Menschen, Art. 38). In addition, the study protocol was reviewed by the ethics committee at the University of Tübingen and received a favorable assessment without any objections to the study conduct (Project Nr. 364/2017BO2).
: Not applicable.
: The authors declare no competing interests.
